Claudiu Bulai Joins AI Startup Quantarium; Lynn Seely Named CEO of Lyell Immunopharma
Claudiu Bulai joined Bellevue AI startup Quantarium as chief innovation officer after five years at Meta’s Reality Labs Research. Lynn Seely became CEO and president of Lyell Immunopharma, succeeding Elizabeth Homans, who will consult through June 2024.
No comments yet.